The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2V617F myeloproliferative neoplasm cellsAriel Amaru Calzada, Josée Golay|Experimental Hematology|2012Cited by 40
Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2V617F myeloproliferative neoplasm patientsAriel Amaru Calzada, Josée Golay|Experimental Hematology|2012Cited by 33